Colonoscopy findings in high-risk individuals compared to an average-risk control population

Scandinavian Journal of Gastroenterology
Anna M ForsbergAnnika Lindblom

Abstract

There is clear evidence of reduced morbidity and mortality from regular colonoscopy programs in patients with Lynch syndrome (LS). Today, also individuals with empirically increased risks of colorectal cancer (CRC) are offered colonoscopic surveillance. The aim was to compare the findings at the first screening colonoscopy in LS carriers, and individuals with an increased risk of bowel cancer due to family history of CRC with a control population. Altogether 1397 individuals with an increased risk for CRC were divided in four risk groups: one with LS carriers and three groups with individuals with different family history of CRC. The findings were compared between the different risk groups and a control group consisting of 745 individuals from a control population who took part in a population-based colonoscopy study. In LS, 30% of the individuals had adenomas and 10% advanced adenomas. The corresponding figures in the other risk groups were 14-24% and 4-7%, compared with 10% and 3% in the control group. The relative risk of having adenomas and advanced adenomas was, compared to controls, significantly higher for all risk groups except the group with the lowest risk. Age was a strong predictor for adenomas and advanced adenomas...Continue Reading

References

Feb 4, 1978·Lancet·M J HillH J Bussey
Nov 1, 1984·Archives of Internal Medicine·R R Love, J F Morrissey
Jul 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H F VasenP Meera Khan
Nov 6, 2001·The American Journal of Gastroenterology·L E Johns, R S Houlston
Nov 18, 2003·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S K ClarkC G Marks
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A LiljegrenA Lindblom
Jan 24, 2006·Journal of Clinical Epidemiology·Laura BagliettoJohn L Hopper
Feb 22, 2007·Journal of the National Cancer Institute·Kristina Lagerstedt RobinsonAnnika Lindblom
Apr 25, 2007·Scandinavian Journal of Gastroenterology·Astrid T StormorkenPål Møller
Sep 11, 2007·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·T MakJ Hill
Jul 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Annelie LiljegrenD Timothy Bishop
Jun 11, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Stephen P NguyenJonathan P Terdiman
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Heikki J JärvinenJukka-Pekka Mecklin
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
May 1, 2010·Lancet·Wendy S AtkinUNKNOWN UK Flexible Sigmoidoscopy Trial Investigators
Sep 14, 2010·Gut·A E van der Meulen-de JongH F A Vasen
Jan 5, 2011·Annals of Internal Medicine·Hermann BrennerMichael Hoffmeister
Aug 1, 2013·International Journal of Cancer. Journal International Du Cancer·David MesherHuw Thomas
Jan 5, 2014·European Journal of Gastroenterology & Hepatology·Lars KjellströmAnna Andreasson

❮ Previous
Next ❯

Citations

Feb 28, 2002·Gastrointestinal Endoscopy·Douglas B NelsonTiina K Johnston

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.